Hyponatraemia can arise from various causes, often multifactorial, making interpretation of diagnostic tests like urinary sodium concentration and osmolality sometimes difficult NICE CKS. Common contributing factors include acute illnesses and certain medications NICE CKS. If a person is taking a medication that may be causing hyponatraemia, it should be stopped if appropriate, with a repeat serum sodium measurement taken after two weeks NICE CKS. If a medication cannot be stopped, specialist advice should be sought to discuss monitoring or referral NICE CKS. If the hyponatraemia persists after stopping a medication, another underlying cause should be assessed, or the person referred to an endocrinologist NICE CKS.
In cases of acute illness contributing to hyponatraemia, treating the underlying problem and rechecking the serum sodium after two weeks, or sooner based on clinical judgement, is recommended NICE CKS. For asymptomatic, mild hyponatraemia (serum sodium 130–135 mmol/L), primary care management may be appropriate, ensuring a repeat serum sodium measurement is taken to rule out a rapidly decreasing concentration, which would necessitate hospital admission NICE CKS.
Severe or acute onset hyponatraemia (less than 48 hours duration or serum sodium <125 mmol/L), or symptomatic hyponatraemia, requires immediate hospital admission NICE CKS. For asymptomatic, moderate hyponatraemia (serum sodium 125–129 mmol/L), discussion with an endocrinologist regarding admission or referral is advised NICE CKS. An urgent 2-week wait referral is indicated if malignant disease is suspected as a cause of SIADH NICE CKS. Referral to an endocrinologist is also recommended if SIADH or another endocrine cause is suspected, or if reset osmostat syndrome or cerebral salt-wasting is suspected NICE CKS. Hyponatraemia related to endocrine disorders is uncommon and requires specialist input NICE CKS. Referral to an appropriate specialist is also recommended if hyponatraemia is thought to be caused by heart failure, kidney disease, or liver disease NICE CKS.
Secondary care management focuses on identifying and treating the underlying cause, with strategies dependent on the onset, symptoms, and volume status NICE CKS. For acute hyponatraemia with moderate to severe symptoms, hypertonic saline is used to restore serum sodium levels and reduce cerebral oedema NICE CKS. In cases of acute hyponatraemia with mild or no symptoms, non-essential parenteral fluids and medications provoking hyponatraemia are stopped, and treatment targets the underlying cause NICE CKS. For chronic hyponatraemia without significant symptoms, similar management of fluids and medications is advised, with treatment directed at the underlying cause NICE CKS. Fluid restriction is recommended for individuals with hypervolaemia or SIADH NICE CKS. Extracellular volume is restored with 0.9% saline for those with hypovolaemia NICE CKS. Tolvaptan is indicated for hyponatraemia secondary to SIADH and should be initiated in hospital or under specialist supervision NICE CKS. Recent literature highlights that hyponatraemia can be a complex condition with various underlying aetiologies [ Buffington & Abreo 2016].
Key References
- CKS - Hyponatraemia
- NG29 - Intravenous fluid therapy in children and young people in hospital
- CG84 - Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management
- CG174 - Intravenous fluid therapy in adults in hospital
- (Buffington and Abreo, 2016): Hyponatremia: A Review.
- (Ball and Iqbal, 2016): Diagnosis and treatment of hyponatraemia.
- (Spasovski, 2024): Hyponatraemia-treatment standard 2024.